Clinical Scorecard: Innovative Biomarkers and Advanced Imaging Techniques in the Diagnosis, Management, and Treatment of Vasculitis Beyond Standard Clinical Criteria
At a Glance
Category
Detail
Condition
Key Mechanisms
Inflammation of blood vessel walls leading to ischemic injury across multiple organ systems, including kidneys, lungs, and skin.
Target Population
Care Setting
Key Highlights
Emerging biomarkers improve diagnostic specificity and monitoring of disease activity.
Advanced imaging techniques provide detailed visualization of vascular inflammation.
2022 ACR/EULAR criteria enhance classification and management of vasculitis.
Individualized treatment strategies are crucial based on emerging biomarkers.
Guideline-Based Recommendations
Diagnosis
Utilize the 2022 ACR/EULAR classification criteria for accurate diagnosis.
Management
Incorporate biomarkers and imaging into clinical decision-making.
Monitoring & Follow-up
Use advanced imaging modalities such as 18F-FDG PET/CT and VW-MRI to assess disease activity and treatment response.
Risks
Overtreatment and undertreatment due to challenges in predicting relapse.
Patient & Prescribing Data
Individualized therapeutic decisions are essential due to the complexity of the disease, including considerations for specific biomarkers and patient history.
Clinical Best Practices
Integrate emerging biomarkers with imaging strategies for comprehensive patient assessment.
Prioritize validated biomarkers and imaging techniques in routine clinical practice, with ongoing education for clinicians.
A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.
